Yaw Bediako net worth
Quick answer
Yaw Bediako's estimated net worth is $5.0M (range $3.5M – $7.5M) as of 2026. Yaw Bediako is Founder at Yemaachi Biotechnology. Yemaachi Biotechnology valuation.
Yaw Bediako is Founder at Yemaachi Biotechnology (YC S21). Independent Entrepreneurial Check model estimate from public YC data.
At a glance
- Company status: Active
- Education: Bachelor's degree in Biology from the University of Ghana; Master's degree in Health Policy and Management from Harvard University.
- Region: Ghana
- Industries: Healthcare, Diagnostics
- Team size: 16
- Website: https://yemaachi.com/
Who is Yaw Bediako?
Yaw Bediako is the co-founder of Yemaachi Biotechnology, a startup focused on genomics and health in Africa.
Highlights:
- University of Ghana
- Harvard University
- Yemaachi Biotechnology
About Yemaachi Biotechnology
Yemaachi Biotech is diversifying and expanding access to precision cancer diagnostics and therapeutics by collecting and sequencing samples from all across Africa, which is the most genetically diverse population on the planet. We then use this data to either optimize existing diagnostic tests, or help other companies discover new ones. With our research activities based in Africa, we are able to leverage access...
FAQ: Yaw Bediako net worth and Yemaachi Biotechnology valuation
What is Yaw Bediako's net worth?
Yaw Bediako's estimated net worth is $5.0M (range $3.5M – $7.5M) as of 2026. Yaw Bediako is Founder at Yemaachi Biotechnology. Entrepreneurial Check publishes an independent model-based estimate from public company and role data. Not verified net worth, and Entrepreneurial Check is not affiliated with Y Combinator or the profiled companies.
What is Yemaachi Biotechnology valuation?
Yemaachi Biotechnology's estimated valuation on Entrepreneurial Check is $20.0M. That valuation, or a disclosed round when one is public, is the source for the paper-wealth estimate. Independent model output — not a verified appraisal or official mark.
What is Yaw Bediako's role?
Yaw Bediako is Founder at Yemaachi Biotechnology, a Y Combinator-backed startup (batch S21).